Raymond James & Associates grew its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 157.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,651 shares of the scientific and technical instruments company's stock after purchasing an additional 12,622 shares during the quarter. Raymond James & Associates owned 0.23% of Transcat worth $2,494,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Hood River Capital Management LLC raised its holdings in Transcat by 21.6% in the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock valued at $23,558,000 after acquiring an additional 34,947 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Transcat by 208.3% during the first quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company's stock worth $1,147,000 after acquiring an additional 6,957 shares during the last quarter. Calamos Advisors LLC grew its position in Transcat by 76.0% in the 2nd quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company's stock valued at $1,848,000 after buying an additional 6,667 shares during the last quarter. Inspire Investing LLC purchased a new position in Transcat in the 2nd quarter valued at $772,000. Finally, Bank of New York Mellon Corp grew its position in Transcat by 23.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 33,181 shares of the scientific and technical instruments company's stock valued at $3,971,000 after buying an additional 6,315 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company's stock.
Transcat Stock Performance
Shares of TRNS stock traded up $7.08 during mid-day trading on Wednesday, reaching $107.00. 126,756 shares of the company were exchanged, compared to its average volume of 54,278. The company has a market capitalization of $979.05 million, a P/E ratio of 50.46 and a beta of 0.69. The business's 50 day simple moving average is $120.65 and its 200 day simple moving average is $122.00. Transcat, Inc. has a fifty-two week low of $85.94 and a fifty-two week high of $147.12.
Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). Transcat had a return on equity of 7.62% and a net margin of 6.63%. The business had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. During the same period in the prior year, the firm earned $0.41 EPS. The business's revenue for the quarter was up 8.0% compared to the same quarter last year. On average, analysts forecast that Transcat, Inc. will post 1.76 EPS for the current year.
Wall Street Analysts Forecast Growth
TRNS has been the subject of a number of research analyst reports. Oppenheimer reiterated an "outperform" rating and issued a $130.00 price target (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Northland Securities cut their price objective on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating on the stock in a report on Wednesday, October 30th. StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a report on Tuesday, October 29th. Craig Hallum cut their price target on shares of Transcat from $138.00 to $113.00 and set a "buy" rating on the stock in a report on Wednesday, October 30th. Finally, HC Wainwright reiterated a "buy" rating and set a $156.00 price objective on shares of Transcat in a research note on Tuesday, October 29th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $127.25.
Read Our Latest Stock Analysis on TRNS
Transcat Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
